№ files_lp_3_process_7_092866
File format: docx
Character count: 3066
File size: 22 KB
Note:
Year
Document type:
Compliance certificate
Organization / institution:
JSE Limited
Target audience:
Issuers with listings on the JSE
Context description:
Legal and financial document used for certifying compliance with listing requirements on the Johannesburg Stock Exchange.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Document type:
Compliance certificate
Form designation:
FORM D1
Stock exchange:
JSE Limited
Applicable listings:
Primary listing; Secondary listing; Interest Rate Market instruments
Regulatory framework:
JSE Listings Requirements; Debt Listings Requirements
Reporting period:
Twelve months ended at the relevant financial year-end
Issuing authority:
JSE Limited
Signatory requirement:
Duly authorised representative on behalf of the directors
Corporate bodies referenced:
Board of directors; Audit committee
Purpose:
Certification of compliance with listing, disclosure, and statutory requirements
Context:
Standardised regulatory source text used by issuers to formally attest compliance with stock exchange obligations during a defined financial period.
Year:
2023
Region / City:
China
Theme:
Securities and Futures Regulations
Document Type:
Template
Institution:
ASIFMA
Author:
ASIFMA
Target Audience:
Industry Participants
Effective Date:
31 March 2023
Approval Date:
17 February 2023
Last Revision Date:
24 February 2023
Note:
Contextual description
Year:
2022
Region / City:
United States
Topic:
Healthcare, Insurance, Balance Billing
Document Type:
Instructional Guide
Organization:
Department of Health and Human Services, Department of Labor, Department of Treasury
Author:
Not specified
Target Audience:
Group health plans, health insurance issuers, beneficiaries, participants
Period of Validity:
From January 1, 2022, ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Compliance Requirement:
Federal and state law compliance
Contact Information:
1-800-985-3059
External Resources:
Plainlanguage.gov/guidelines, Section508.gov, LEP.gov
Description:
A regulatory document providing guidelines for group health plans and health insurance issuers on disclosure requirements related to balance billing protections and related healthcare services.
Year:
2023
Region / City:
Taiwan
Subject:
Foreign Issuers, Emerging Stock Market
Document Type:
FAQ
Organization:
TPEx (Taipei Exchange)
Author:
TPEx
Target Audience:
Foreign enterprises, financial professionals
Period of Validity:
Not specified
Approval Date:
November 30, 2023
Date of Changes:
Not specified
Note:
Year
Type of Document:
Annual financial statement questionnaire
Applicable Standards:
International Financial Reporting Standards, South African financial reporting requirements
Scope:
Consolidated group financial statements
Required Disclosures:
Directors’ interests, major shareholders, public shareholders, share incentive schemes, individual directors’ remuneration, transactions, issues for cash, repurchased equity securities, property entity reporting, investment trust reporting, restrictive funding arrangements
Auditor:
Specified in compliance with reporting requirements
Relevant Sections:
8.62, 8.63, Practice Note 3/2017
Year:
2024
Region / City:
Global
Topic:
ETFs, Investment Strategies, Fixed Income, ESG
Document Type:
Interview
Institution:
AXA Investment Managers
Author:
Margareta Hricova, Olivier Paquier, Deborah Fuhr
Target Audience:
Investors, Financial Professionals
Period of Validity:
Until 2024
Date of Approval:
2024
Date of Modifications:
N/A
Year:
2011
Regulation:
The Companies Regulations 2011, as amended
Region / Market:
Johannesburg Stock Exchange (JSE)
Document Type:
Regulatory guidance / compliance document
Scope:
Pre-Listing Statements (PLS), Revised Listing Particulars (RLP), Circulars
Language:
English
Applicable Parties:
Issuers and applicants seeking listing on JSE
Requirements:
Disclosure obligations, material contracts, corporate actions
Website Obligation:
Operational website for disclosure compliance
Audience:
Investors, shareholders
Document type:
Compliance certificate
Form designation:
FORM D1
Stock exchange:
JSE Limited
Applicable listings:
Primary listing; Secondary listing; Interest Rate Market instruments
Regulatory framework:
JSE Listings Requirements; Debt Listings Requirements
Reporting period:
Twelve months ended at the relevant financial year-end
Issuing authority:
JSE Limited
Signatory requirement:
Duly authorised representative on behalf of the directors
Corporate bodies referenced:
Board of directors; Audit committee
Purpose:
Certification of compliance with listing, disclosure, and statutory requirements
Context:
Standardised regulatory source text used by issuers to formally attest compliance with stock exchange obligations during a defined financial period.
Year:
2021
Month:
March
Jurisdiction:
South Africa
Region:
South African financial markets
Theme:
Securities regulation and listing requirements
Document type:
Consultation paper
Issuing body:
JSE Limited
Division:
Issuer Regulation Division
Author:
Issuer Regulation Division, JSE Limited
Director responsible:
André Visser
Target audience:
Market participants and stakeholders
Markets concerned:
Main Board and Alternative Exchange (AltX)
Legal framework referenced:
JSE Listings Requirements; Financial Markets Act No. 19 of 2012
Consultation deadline:
9 April 2021
Purpose:
Request for comments on potential regulatory amendments
Status:
Non-binding consultation initiative
Source type:
Regulatory consultation document
Note:
Year
Context:
This document outlines the listing requirements and procedures for sponsored and unsponsored Depository Receipts (DRs) under the Johannesburg Stock Exchange (JSE).
Year:
2022
Region / City:
Jamaica
Subject:
Employment Tax Credit, Jamaica Stock Exchange Junior Market
Document Type:
Technical Advisory
Issuing Organization:
Tax Administration Jamaica (TAJ)
Author:
Tax Administration Jamaica
Target Audience:
Companies listed on the JSE Junior Market
Period of Validity:
Not specified
Approval Date:
November 10, 2022
Date of Changes:
Not specified
Year:
2025
Region / City:
South Africa
Theme:
Corporate Actions
Document Type:
Proposal
Organization / Institution:
Johannesburg Stock Exchange
Author:
Sharon Nair
Target Audience:
Stakeholders in corporate actions, financial institutions, and securities holders
Effective Period:
2025
Approval Date:
Not specified
Date of Changes:
Not specified
Date:
23 June 2016
Subject:
New Financial Instrument Listing (FORTRESS INCOME FUND LIMITED – FIFB09)
Exchange:
JSE Limited
Market:
Interest Rate Market
Issuer:
Fortress Income Fund Limited
Instrument Type:
Floating Rate Note
Bond Code:
FIFB09
ISIN:
ZAG000137654
Nominal Issued:
R 200,000,000.00
Issue Price:
100%
Coupon:
9.165% (3 Month JIBAR as at 22 June 2016 of 7.325% plus 184 bps)
Coupon Rate Indicator:
Floating
Trade Type:
Price
Issue Date:
27 June 2016
Interest Commencement Date:
27 June 2016
First Interest Payment Date:
27 September 2016
Interest Payment Dates:
27 March, 27 June, 27 September, 27 December
Books Close Dates:
17 March, 16 June, 17 September, 17 December
Last Day to Register:
By 17:00 on 16 March, 15 June, 16 September, 16 December
Final Maturity Date:
27 June 2019
Date Convention:
Following
Security Status:
Senior Unsecured Floating Rate Notes
Settlement System:
Central Securities Depository (CSD) electronic settlement
Related Document:
Applicable Pricing Supplement
Contact – Issuer Representative:
Courtney Galloway, RMB, +27 11 2824155
Contact – Exchange:
Corporate Actions, JSE, +27 11 5207000
Date:
12 March 2021
Exchange:
JSE Limited
Market:
Interest Rate Market
Subject:
New Financial Instrument Listing
Issuer:
FIRSTRAND BANK LIMITED
Instrument Type:
Equity Structured Note
Bond Code:
FRS258
ISIN:
ZAG000174855
Nominal Issued:
R 260,392,055.00
Issue Price:
100%
Coupon:
Zero
Trade Type:
Price
Issue Date:
16 March 2021
Interest Commencement Date:
16 March 2021
First Interest Payment Date:
23 January 2024
Interest Payment Date(s):
23 January 2024
Books Close Date:
19 January 2024
Last Day to Register:
by 17:00 on 18 January 2024
Final Maturity Date:
23 January 2024
Security:
Unsecured
Settlement System:
Central Securities Depository (CSD) electronic settlement in terms of JSE Rules
Applicable Pricing Supplement:
https://clientportal.jse.co.za/Content/JSEPricingSupplementsItems/2021/FRS258%20PricingSupplement1603.pdf
Contact:
Corporate Actions, JSE, +27 11 5207000
Currency:
South African Rand (R)
Note:
Year
Type of Document:
Annual financial statement questionnaire
Applicable Standards:
International Financial Reporting Standards, South African financial reporting requirements
Scope:
Consolidated group financial statements
Required Disclosures:
Directors’ interests, major shareholders, public shareholders, share incentive schemes, individual directors’ remuneration, transactions, issues for cash, repurchased equity securities, property entity reporting, investment trust reporting, restrictive funding arrangements
Auditor:
Specified in compliance with reporting requirements
Relevant Sections:
8.62, 8.63, Practice Note 3/2017
Year:
2025
Organization:
Johannesburg Stock Exchange (JSE)
Document Type:
Consultation Paper / Comments Template
Audience:
Market participants and stakeholders
Scope:
Financial reporting, non-IFRS measures, corporate governance, trading statements, headline earnings per share
Jurisdiction:
South Africa
Related Standards:
IFRS 18, JSE Listings Requirements
Submission Format:
Name, Organisation, Date, Consent confirmation
Privacy Policy Reference:
https://www.jse.co.za/privacy-policy
Year:
2023
Organization:
Johannesburg Stock Exchange (JSE)
Document Type:
Regulatory update / guideline
Scope:
Listing requirements and amendments to Sections 4, 14, 15, 18, 20, 21
Target Audience:
Issuers, sponsors, advisers
Period Covered:
September 2023 – Final Release
Key Sections:
Conditions of Listing, Pyramids, Investment Entities, Secondary Listings, Hybrid Securities, AltX, New Listings
Purpose:
Simplification of legal language, reduction of red tape, clarification of listing criteria
Amendments Included:
Section 5 Independent Fairness Opinion, Schedule 10 MOI requirements, Section 11 Rescue Operations, Schedule 14 Share Incentive Scheme
Context:
Official source document detailing final simplification and structural amendments to the JSE listing requirements to streamline criteria, remove outdated legal language, and clarify obligations for issuers and sponsors
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
2025
Region / city:
Australia
Subject:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Benefits Scheme (PBS) Submission
Organ / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval Date:
Pending
Date of modifications:
N/A
Year:
2025
Region / City:
Uganda
Theme:
Procurement, Health Services, Public Contracts
Document Type:
Pre-Qualification Notice
Authority:
Mulago Specialised Women and Neonatal Hospital
Author:
Not specified
Target Audience:
Providers, Contractors, Suppliers
Period of Validity:
2025-2028
Approval Date:
Not specified
Amendment Date:
Not specified